Skip to content

Weight Loss Strategies in 2024 and Beyond: Treatment of Obesity in the Era of Novel Weight Loss Medications (M42)

Monday, March 4 • 4:00 PM – 5:30 PM ET

In Person_Virtual


  1. Outline the physiology of food regulation and use of weight loss medications for appetite regulation.
  2. Discuss the importance of lifestyle modifications in maintaining weight loss for patients using novel weight loss medications. 
  3. Discuss how endo-bariatric procedures fit within current obesity treatment algorithms with provision of multi-modal care.
  4. Discuss role of anti-obesity medications as "neo-adjuvant" and "adjuvant" treatment strategies for weight management in the surgical population.


Weight Loss Medications
Manpreet Mundi, MD, Professor of Medicine; Medical Director of Clinical Nutrition and the Home Enteral Nutrition Program, Department of Endocrinology, Mayo Clinic College of Medicine and Science, Rochester, MN

Lifestyle Interventions
Danelle Olson, MS, RDN, LD, CNSC, Advanced Practice I Dietitian, Home Parenteral and Enteral Nutrition, Mayo Clinic, Rochester, MN

Endoscopic Interventions For Weight Loss
Carolyn Newberry, MD, Assistant Professor, Department of Medicine, Division of Gastroenterology, Weill Cornell Medical Center, New York, NY

Bariatric Surgery
Victoria Gershuni, MD, MTR, MSGM, Assistant Professor of Surgery, Hospital of the University of Pennsylvania; Advanced Gastrointestinal, Foregut, and Bariatric Surgeon, Penn Medicine, Philadelphia, PA

Manpreet Mundi, MD

CE Credit: 1.5 hours
Level: Intermediate
UAN: JA0002345-0000-24-064-L01-P

BCNSP Logo 2024  This session will be reviewed for BCNSP-approved recertification credit through Purdue University College of Pharmacy